|Values are valid only on day of printing.|
Ambiguous genitalia detected on prenatal ultrasound, particularly when fetus is confirmed XX female by chromosome analysis
Pregnancies at risk for 21-hydroxylase deficient congenital adrenal hyperplasia based on family history
This test includes Sanger gene sequencing and multiplex ligation-dependent probe amplification to evaluate for the 21-hydroxylase gene (CYP21A2) on prenatal specimens.
|Test ID||Reporting Name||Available Separately||Always Performed|
|MATCC||Maternal Cell Contamination, B||Yes||No|
|CULFB||Fibroblast Culture for Genetic Test||Yes||No|
|CULAF||Amniotic Fluid Culture/Genetic Test||Yes||No|
If amniotic fluid (nonconfluent cultured cells) is received, amniotic fluid culture/genetic test will be added per laboratory protocol and charged separately.
If chorionic villus specimen (nonconfluent cultured cells) is received, fibroblast culture for genetic test will be added per laboratory protocol and charged separately.
For any prenatal specimen that is received, maternal cell contamination testing will be added per laboratory protocol and charged separately.
Polymerase Chain Reaction (PCR) Amplification/DNA Sequencing and Deletion Detection by Multiplex Ligation-Dependent Probe Amplification (MLPA)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)